List of Tables
Table 1. Global Diabetic Neuropathy Treatment Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Diabetic Neuropathy Treatment Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Diabetic Neuropathy Treatment Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Diabetic Neuropathy Treatment Drug Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Diabetic Neuropathy Treatment Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Diabetic Neuropathy Treatment Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Diabetic Neuropathy Treatment Drug Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Diabetic Neuropathy Treatment Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Diabetic Neuropathy Treatment Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Diabetic Neuropathy Treatment Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Diabetic Neuropathy Treatment Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diabetic Neuropathy Treatment Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Diabetic Neuropathy Treatment Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diabetic Neuropathy Treatment Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Diabetic Neuropathy Treatment Drug Sales by Region (K Dose), 2021–2026
Table 18. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Region (2021–2026)
Table 19. Global Diabetic Neuropathy Treatment Drug Sales by Region (K Dose), 2027–2032
Table 20. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Region (2027–2032)
Table 21. Global Diabetic Neuropathy Treatment Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Diabetic Neuropathy Treatment Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Diabetic Neuropathy Treatment Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Diabetic Neuropathy Treatment Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Diabetic Neuropathy Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2021–2026
Table 27. North America Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2027–2032
Table 28. North America Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Diabetic Neuropathy Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2021–2026
Table 32. Europe Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2027–2032
Table 33. Europe Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Diabetic Neuropathy Treatment Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Diabetic Neuropathy Treatment Drug Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Diabetic Neuropathy Treatment Drug Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Diabetic Neuropathy Treatment Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Diabetic Neuropathy Treatment Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Diabetic Neuropathy Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2021–2026
Table 42. Latin America Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2027–2032
Table 43. Latin America Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Diabetic Neuropathy Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Diabetic Neuropathy Treatment Drug Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Diabetic Neuropathy Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Diabetic Neuropathy Treatment Drug Sales (K Dose) by Type (2021–2026)
Table 51. Global Diabetic Neuropathy Treatment Drug Sales (K Dose) by Type (2027–2032)
Table 52. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Type (2021–2026)
Table 53. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Type (2027–2032)
Table 54. Global Diabetic Neuropathy Treatment Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Diabetic Neuropathy Treatment Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Diabetic Neuropathy Treatment Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Diabetic Neuropathy Treatment Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Diabetic Neuropathy Treatment Drug Price (US$/Dose) by Type (2021–2026)
Table 59. Global Diabetic Neuropathy Treatment Drug Price (US$/Dose) by Type (2027–2032)
Table 60. Global Diabetic Neuropathy Treatment Drug Sales (K Dose) by Application (2021–2026)
Table 61. Global Diabetic Neuropathy Treatment Drug Sales (K Dose) by Application (2027–2032)
Table 62. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Application (2021–2026)
Table 63. Global Diabetic Neuropathy Treatment Drug Sales Market Share by Application (2027–2032)
Table 64. Global Diabetic Neuropathy Treatment Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Diabetic Neuropathy Treatment Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Diabetic Neuropathy Treatment Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Diabetic Neuropathy Treatment Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Diabetic Neuropathy Treatment Drug Price (US$/Dose) by Application (2021–2026)
Table 69. Global Diabetic Neuropathy Treatment Drug Price (US$/Dose) by Application (2027–2032)
Table 70. Abbott Laboratories Company Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Abbott Laboratories Diabetic Neuropathy Treatment Drug Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. Eli Lilly And Company Company Information
Table 76. Eli Lilly And Company Description and Business Overview
Table 77. Eli Lilly And Company Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Eli Lilly And Company Diabetic Neuropathy Treatment Drug Product
Table 79. Eli Lilly And Company Recent Developments/Updates
Table 80. Pfizer, Inc. Company Information
Table 81. Pfizer, Inc. Description and Business Overview
Table 82. Pfizer, Inc. Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Pfizer, Inc. Diabetic Neuropathy Treatment Drug Product
Table 84. Pfizer, Inc. Recent Developments/Updates
Table 85. Lupin Limited Company Information
Table 86. Lupin Limited Description and Business Overview
Table 87. Lupin Limited Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Lupin Limited Diabetic Neuropathy Treatment Drug Product
Table 89. Lupin Limited Recent Developments/Updates
Table 90. Astellas Pharma, Inc. Company Information
Table 91. Astellas Pharma, Inc. Description and Business Overview
Table 92. Astellas Pharma, Inc. Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Astellas Pharma, Inc. Diabetic Neuropathy Treatment Drug Product
Table 94. Astellas Pharma, Inc. Recent Developments/Updates
Table 95. Glenmark Pharmaceuticals Limited Company Information
Table 96. Glenmark Pharmaceuticals Limited Description and Business Overview
Table 97. Glenmark Pharmaceuticals Limited Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Glenmark Pharmaceuticals Limited Diabetic Neuropathy Treatment Drug Product
Table 99. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 100. Boehringer Ingelheim International GmbH Company Information
Table 101. Boehringer Ingelheim International GmbH Description and Business Overview
Table 102. Boehringer Ingelheim International GmbH Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Boehringer Ingelheim International GmbH Diabetic Neuropathy Treatment Drug Product
Table 104. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 105. Novartis AG Company Information
Table 106. Novartis AG Description and Business Overview
Table 107. Novartis AG Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Novartis AG Diabetic Neuropathy Treatment Drug Product
Table 109. Novartis AG Recent Developments/Updates
Table 110. McKesson Corporation Company Information
Table 111. McKesson Corporation Description and Business Overview
Table 112. McKesson Corporation Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. McKesson Corporation Diabetic Neuropathy Treatment Drug Product
Table 114. McKesson Corporation Recent Developments/Updates
Table 115. GlaxoSmithKline PLC (GSK) Company Information
Table 116. GlaxoSmithKline PLC (GSK) Description and Business Overview
Table 117. GlaxoSmithKline PLC (GSK) Diabetic Neuropathy Treatment Drug Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. GlaxoSmithKline PLC (GSK) Diabetic Neuropathy Treatment Drug Product
Table 119. GlaxoSmithKline PLC (GSK) Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Diabetic Neuropathy Treatment Drug Distributors List
Table 123. Diabetic Neuropathy Treatment Drug Customers List
Table 124. Diabetic Neuropathy Treatment Drug Market Trends
Table 125. Diabetic Neuropathy Treatment Drug Market Drivers
Table 126. Diabetic Neuropathy Treatment Drug Market Challenges
Table 127. Diabetic Neuropathy Treatment Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Diabetic Neuropathy Treatment Drug
Figure 2. Global Diabetic Neuropathy Treatment Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Diabetic Neuropathy Treatment Drug Market Share by Type: 2025 & 2032
Figure 4. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 5. Antidepressants Product Picture
Figure 6. Opioid Product Picture
Figure 7. Capsaicin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Diabetic Neuropathy Treatment Drug Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Diabetic Neuropathy Treatment Drug Market Share by Application: 2025 & 2032
Figure 11. Hospitals Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Others
Figure 14. Global Diabetic Neuropathy Treatment Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Diabetic Neuropathy Treatment Drug Market Size (US$ Million), 2021–2032
Figure 16. Global Diabetic Neuropathy Treatment Drug Sales (K Dose), 2021–2032
Figure 17. Global Diabetic Neuropathy Treatment Drug Average Price (US$/Dose), 2021–2032
Figure 18. Diabetic Neuropathy Treatment Drug Report Years Considered
Figure 19. Diabetic Neuropathy Treatment Drug Sales Share by Manufacturers in 2025
Figure 20. Global Diabetic Neuropathy Treatment Drug Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Diabetic Neuropathy Treatment Drug Players: Market Share by Revenue in Diabetic Neuropathy Treatment Drug in 2025
Figure 22. Diabetic Neuropathy Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Diabetic Neuropathy Treatment Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Diabetic Neuropathy Treatment Drug Sales Market Share by Country (2021–2032)
Figure 25. North America Diabetic Neuropathy Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 26. United States Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Diabetic Neuropathy Treatment Drug Sales Market Share by Country (2021–2032)
Figure 29. Europe Diabetic Neuropathy Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 30. Germany Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Diabetic Neuropathy Treatment Drug Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Diabetic Neuropathy Treatment Drug Revenue Market Share by Region (2021–2032)
Figure 37. China Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Diabetic Neuropathy Treatment Drug Sales Market Share by Country (2021–2032)
Figure 45. Latin America Diabetic Neuropathy Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Diabetic Neuropathy Treatment Drug Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Diabetic Neuropathy Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Diabetic Neuropathy Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Diabetic Neuropathy Treatment Drug by Type (2021–2032)
Figure 56. Global Revenue Market Share of Diabetic Neuropathy Treatment Drug by Type (2021–2032)
Figure 57. Global Diabetic Neuropathy Treatment Drug Price (US$/Dose) by Type (2021–2032)
Figure 58. Global Sales Market Share of Diabetic Neuropathy Treatment Drug by Application (2021–2032)
Figure 59. Global Revenue Market Share of Diabetic Neuropathy Treatment Drug by Application (2021–2032)
Figure 60. Global Diabetic Neuropathy Treatment Drug Price (US$/Dose) by Application (2021–2032)
Figure 61. Diabetic Neuropathy Treatment Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
